vs
Side-by-side financial comparison of Evolus, Inc. (EOLS) and Primis Financial Corp. (FRST). Click either name above to swap in a different company.
Evolus, Inc. is the larger business by last-quarter revenue ($73.1M vs $45.6M, roughly 1.6× Primis Financial Corp.). Primis Financial Corp. runs the higher net margin — 16.0% vs -14.6%, a 30.6% gap on every dollar of revenue. Over the past eight quarters, Primis Financial Corp.'s revenue compounded faster (13.0% CAGR vs 4.6%).
Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.
Primis Financial Corp is a U.S.-based financial holding company operating full-service banking subsidiaries. It provides a comprehensive range of financial solutions including personal and commercial deposit products, diverse loan facilities, mortgage services, and wealth management support, primarily serving retail and corporate customers across the U.S. mid-Atlantic region.
EOLS vs FRST — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $73.1M | $45.6M |
| Net Profit | $-10.7M | $7.3M |
| Gross Margin | 66.9% | — |
| Operating Margin | 23.8% | — |
| Net Margin | -14.6% | 16.0% |
| Revenue YoY | 6.7% | — |
| Net Profit YoY | — | 200.0% |
| EPS (diluted) | $-0.16 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $73.1M | $45.6M | ||
| Q4 25 | $90.3M | $80.9M | ||
| Q3 25 | $69.0M | $41.0M | ||
| Q2 25 | $69.4M | $43.2M | ||
| Q1 25 | $68.5M | $58.7M | ||
| Q4 24 | $78.9M | $38.8M | ||
| Q3 24 | $61.1M | $37.3M | ||
| Q2 24 | $66.9M | $35.7M |
| Q1 26 | $-10.7M | $7.3M | ||
| Q4 25 | $130.0K | $29.5M | ||
| Q3 25 | $-15.7M | $6.8M | ||
| Q2 25 | $-17.1M | $2.4M | ||
| Q1 25 | $-18.9M | $22.6M | ||
| Q4 24 | $-6.8M | $-26.2M | ||
| Q3 24 | $-19.2M | $1.2M | ||
| Q2 24 | $-11.3M | $3.4M |
| Q1 26 | 66.9% | — | ||
| Q4 25 | 65.7% | — | ||
| Q3 25 | 66.5% | — | ||
| Q2 25 | 65.3% | — | ||
| Q1 25 | 68.1% | — | ||
| Q4 24 | 66.7% | — | ||
| Q3 24 | 68.9% | — | ||
| Q2 24 | 70.3% | — |
| Q1 26 | 23.8% | — | ||
| Q4 25 | 4.7% | 44.8% | ||
| Q3 25 | -16.7% | 21.3% | ||
| Q2 25 | -14.7% | 6.9% | ||
| Q1 25 | -22.1% | 41.9% | ||
| Q4 24 | -2.9% | -123.0% | ||
| Q3 24 | -25.3% | -3.1% | ||
| Q2 24 | -11.5% | 7.8% |
| Q1 26 | -14.6% | 16.0% | ||
| Q4 25 | 0.1% | 36.5% | ||
| Q3 25 | -22.8% | 16.7% | ||
| Q2 25 | -24.7% | 5.6% | ||
| Q1 25 | -27.6% | 38.6% | ||
| Q4 24 | -8.6% | -100.3% | ||
| Q3 24 | -31.4% | 3.3% | ||
| Q2 24 | -17.0% | 9.6% |
| Q1 26 | $-0.16 | $0.30 | ||
| Q4 25 | $0.01 | $1.19 | ||
| Q3 25 | $-0.24 | $0.28 | ||
| Q2 25 | $-0.27 | $0.10 | ||
| Q1 25 | $-0.30 | $0.92 | ||
| Q4 24 | $-0.11 | $-0.95 | ||
| Q3 24 | $-0.30 | $0.05 | ||
| Q2 24 | $-0.18 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $49.8M | $159.9M |
| Total DebtLower is stronger | $156.4M | — |
| Stockholders' EquityBook value | — | $427.2M |
| Total Assets | $220.6M | $4.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $49.8M | $159.9M | ||
| Q4 25 | $53.8M | $143.6M | ||
| Q3 25 | $43.5M | $63.9M | ||
| Q2 25 | $61.7M | $94.1M | ||
| Q1 25 | $67.9M | $57.0M | ||
| Q4 24 | $87.0M | $64.5M | ||
| Q3 24 | $85.0M | $77.3M | ||
| Q2 24 | $93.7M | $66.6M |
| Q1 26 | $156.4M | — | ||
| Q4 25 | $146.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $121.8M | — | ||
| Q4 24 | $121.5M | — | ||
| Q3 24 | $121.2M | — | ||
| Q2 24 | $120.9M | — |
| Q1 26 | — | $427.2M | ||
| Q4 25 | $-23.1M | $422.9M | ||
| Q3 25 | $-28.8M | $382.2M | ||
| Q2 25 | $-18.7M | $376.4M | ||
| Q1 25 | $-6.6M | $375.6M | ||
| Q4 24 | $5.5M | $351.8M | ||
| Q3 24 | $5.9M | $381.0M | ||
| Q2 24 | $19.3M | $376.0M |
| Q1 26 | $220.6M | $4.3B | ||
| Q4 25 | $225.9M | $4.0B | ||
| Q3 25 | $219.0M | $4.0B | ||
| Q2 25 | $228.8M | $3.9B | ||
| Q1 25 | $213.4M | $3.7B | ||
| Q4 24 | $232.6M | $3.7B | ||
| Q3 24 | $229.6M | $4.0B | ||
| Q2 24 | $233.8M | $4.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 22.00× | — | ||
| Q3 24 | 20.58× | — | ||
| Q2 24 | 6.26× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EOLS
| Product revenue, net | $72.7M | 99% |
| Service revenue | $390.0K | 1% |
FRST
| Net Interest Income | $32.1M | 70% |
| Noninterest Income | $13.6M | 30% |
